relatlimab   Click here for help

GtoPdb Ligand ID: 9536

Synonyms: BMS-986016 | BMS986016 | ONO-4482 | Opdualag® (nivolumab + relatlimab-rmbw) | relatlimab-rmbw
Approved drug Immunopharmacology Ligand
relatlimab is an approved drug (FDA (2022))
Compound class: Antibody
Comment: Relatlimab (BMS-986016) is an anti-LAG3 monoclonal antibody that was developed for utility in cancer immunotherapy.
Immunopharmacology Comments
BMS-986016 is an immunomodulatory monoclonal antibody targeting the inhibitory receptor, T cell co-stimulatory protein, LAG3.